NCT03556605 is a NA clinical trial of OneTouch Reveal® Mobile APP system in Diabetes Mellitus, sponsored by LifeScan.

Who is sponsoring NCT03556605?

NCT03556605 is sponsored by LifeScan.

What drugs are being tested in NCT03556605?

Interventions in NCT03556605: OneTouch Reveal® Mobile APP system, Current Blood Glucose Monitor.

What condition does NCT03556605 study?

NCT03556605 studies Diabetes Mellitus.

Is NCT03556605 still recruiting?

NCT03556605 is currently status unknown. Last updated 31 January 2019.

Last reviewed 2019-01-31 · How we verify

NCT03556605

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tu Salud (Your Health) Randomized Control Study in Patients With Diabetes Using a Mobile App.

Status unknown NA Last updated 31 January 2019

What this trial tests

NA trial testing OneTouch Reveal® Mobile APP system in Diabetes Mellitus in 100 participants. Status unknown.

Timeline

30 July 2018

Primary endpoint
15 September 2019

15 September 2019

Quick facts

Lead sponsor	LifeScan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	30 July 2018
Primary completion	15 September 2019
Estimated completion	15 September 2019
Sites	1 location across United States

Drugs / interventions tested

OneTouch Reveal® Mobile APP system
Current Blood Glucose Monitor

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

LifeScan

Who can join

18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study seeks to demonstrate the clinical value and user acceptance of the Bluetooth enabled OneTouch Verio® Flex meter (Flex) used in combination with the OneTouch Reveal® Mobile APP to support overall diabetes care, glycemic control and patient reported outcomes in patients with diabetes in an undeserved population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Use of a Meter With Color-Range Indicators and a Mobile Diabetes Management App Improved Glycemic Control and Patient Satisfaction in an Underserved Hispanic Population: "Tu Salud"-A Randomized Controlled Partial Cross-Over Clinical Study.
Katz LB, Aparicio M, Cameron H, Ceppa F. · · 2022 · cited 6× · PMID 35308153 · DOI 10.2337/ds20-0101

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other LifeScan trials

Trials by the same sponsor.

NCT05354297 — Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions · NA · unknown
NCT03138174 — OneTouch Verio Flex System Accuracy Evaluation · completed
NCT02929654 — Assessment of Blood Glucose Monitoring Devices With New Insight Features · NA · completed
NCT03189225 — Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI · NA · completed
NCT02374879 — User Performance and System Accuracy Evaluations Using Glucose Adjustment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03556605 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by LifeScan
Last refreshed: 31 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03556605.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing